Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Studies to Explore the Relation Between Angiogenic Markers and the Treatment Response With Carboplatin, Paclitaxel and Bevacizumab in First Line of Advanced Non-small-cell Lung Cancer With Non- Squamous Histology

NCT01814163 is registered in ClinicalTrials.gov with Spanish Lung Cancer Group as lead sponsor.

NCT NCT01814163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01814163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Studies to Explore the Relation Between Angiogenic Markers and the Treatment Response With Carboplatin, Paclitaxel and Bevacizumab in First Line of Advanced Non-small-cell Lung Cancer With Non- Squamous Histology
Lead sponsor
Spanish Lung Cancer Group
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
February 28, 2013
Enrollment
200 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

nonsquamous nonsmall cell neoplasm of lung